Hims & Hers Chief Accounting Officer Irene Becklund to Step Down in October 2026

Transition Timeline and Advisory Arrangement Details

Irene Becklund communicated her resignation to Hims & Hers on July 13, 2026, with an effective departure date of October 9, 2026. This provides approximately three months for the company to facilitate an orderly leadership transition in the accounting function. Rather than a clean break, the company has structured a continuation arrangement to ensure operational continuity during the handover period.

The advisory agreement between Becklund and the company will commence on October 10, 2026, the day after her formal resignation takes effect, and will extend through July 10, 2027. Under this arrangement, Ms. Becklund will provide advisory support to the organization, maintaining institutional knowledge and assisting with the transfer of responsibilities to new accounting leadership. This nine-month advisory window demonstrates the company's commitment to a smooth transition in a critical financial oversight role.

Becklund's Tenure in Accounting Leadership Roles

Ms. Becklund has held significant responsibility within Hims & Hers' finance and accounting operations. She assumed the role of Chief Accounting Officer in April 2025, representing a relatively recent elevation within the company's executive structure. Prior to this appointment, she served as Principal Accounting Officer beginning in November 2021, a position she has maintained alongside her Chief Accounting Officer responsibilities since the 2025 transition.

Her tenure spanning from November 2021 through October 2026 encompasses a period of growth and operational development for the telehealth and direct-to-consumer healthcare platform. Throughout this time, she oversaw accounting practices, financial reporting accuracy, and compliance with regulatory requirements governing healthcare and publicly traded companies. Her experience in both roles positions her well to provide valuable guidance during the upcoming transition period.

Absence of Accounting Disputes or Financial Reporting Concerns

Hims & Hers explicitly stated that Ms. Becklund's resignation stems from her own decision and is not precipitated by any disagreement with the company's accounting principles, practices, or financial statements and disclosures. This clarification is significant because it signals to investors and stakeholders that the departure does not reflect underlying concerns about financial reporting integrity or accuracy. The company disclosed this through formal channels to provide transparency regarding the circumstances of the executive transition.

The absence of any dispute over accounting policies or financial presentations is an important distinction in evaluating executive departures within finance and accounting functions. Such circumstances could indicate normal career progression, personal considerations, or timing decisions rather than potential regulatory or operational red flags. The company's affirmation of harmonious professional separation provides assurance to investors monitoring financial leadership stability.

Hims & Hers Business Model and Financial Oversight Importance

Hims & Hers operates as a digital health platform providing telemedicine services and direct-to-consumer healthcare solutions. The company's business model involves delivering prescription medications, telehealth consultations, and health assessments through digital channels. As a publicly traded healthcare company operating under both healthcare regulations and securities laws, robust accounting and financial reporting functions are essential to operational compliance and investor confidence.

The Chief Accounting Officer and Principal Accounting Officer roles carry heightened responsibility in the healthcare sector, where regulatory oversight is intensive and financial disclosures must meet stringent standards. These executives ensure accurate revenue recognition from telehealth services, proper tracking of inventory for pharmaceutical products, and compliance with healthcare billing regulations. The transition in this critical function requires careful management to maintain the accuracy and timeliness of financial information provided to investors and regulators.

Executive Leadership and Governance Continuity

The announcement was signed by Andrew Dudum, Chief Executive Officer of Hims & Hers, on July 17, 2026. The CEO's direct involvement in communicating the transition underscores the company's commitment to transparent governance communication regarding changes in senior financial leadership. The formality of the disclosure through regulatory channels demonstrates adherence to securities reporting obligations when material changes occur in officer positions.

The company's handling of this leadership transition reflects standard corporate governance practices for publicly traded healthcare companies. By immediately engaging an advisory agreement with the departing Chief Accounting Officer, Hims & Hers demonstrates proactive planning to minimize operational disruption. This approach is consistent with best practices in executive transitions within regulated industries where continuity in financial oversight and reporting maintains shareholder trust and regulatory compliance.

Implications for Investor Monitoring and Future Disclosures

Investors should monitor future disclosures from Hims & Hers regarding the appointment of a successor Chief Accounting Officer and Principal Accounting Officer. The company is required to report such appointments through appropriate regulatory channels once a replacement has been identified and hired. The interim period during which Ms. Becklund serves in an advisory capacity will be an important transition window for knowledge transfer and process documentation.

The structured nine-month advisory engagement suggests the company recognizes the importance of maintaining continuity in accounting oversight. Investors may wish to track whether the company experiences any changes in audit findings, financial reporting timelines, or restatements during and after the transition period. Additionally, the qualifications and background of any successor Chief Accounting Officer will be relevant to assessing the depth of financial leadership within the organization going forward.

Delaware Incorporation and Regulatory Compliance Framework

Hims & Hers is incorporated in Delaware and operates under Delaware corporate law governance standards. The company's Class A Common Stock trades on the New York Stock Exchange under the ticker HIMS. As a publicly traded company, Hims & Hers maintains filing obligations with the Securities and Exchange Commission, including timely disclosure of material changes in executive officers and significant governance matters.

The disclosure of Ms. Becklund's resignation and the advisory arrangement reflects the company's compliance with these reporting requirements. The filing was made within required timeframes, with the earliest event reported on July 13, 2026, and the formal disclosure submitted on July 17, 2026. This adherence to regulatory timelines demonstrates the company's commitment to providing investors with material information about changes in leadership that could affect financial reporting and internal control functions.

Industry Context for Telehealth Executive Leadership

The telehealth and direct-to-consumer healthcare sector has experienced significant growth and evolution in recent years. Companies operating in this space must navigate complex regulatory environments encompassing healthcare compliance, pharmaceutical licensing, state-by-state telemedicine regulations, and securities law requirements. The accounting and financial reporting functions in such companies require sophisticated expertise to address unique revenue recognition challenges, healthcare billing regulations, and compliance tracking.

Executive transitions in financial leadership roles within telehealth companies can have broader implications for operational continuity and regulatory compliance. The transition period at Hims & Hers, supported by Ms. Becklund's advisory engagement, allows the company to maintain institutional knowledge while recruiting and training a successor. This approach is particularly relevant in a sector where regulatory changes and operational complexity demand deep organizational understanding from accounting leadership.

Principal Place of Business and Operational Structure

Hims & Hers maintains its principal executive offices at 2269 Chestnut Street, Suite 523, in San Francisco, California. This San Francisco location serves as the headquarters for the company's operations and executive management. The company's IRS Employer Identification Number is 98-1482650, and its SEC Commission File Number is 001-38986, providing regulatory identification information for investors tracking the organization.

The company's San Francisco base places it within the technology and healthcare innovation corridor of California, reflecting the digital-first nature of its business model. The headquarters location houses the executive functions, including the Chief Accounting Officer and Principal Accounting Officer roles that Ms. Becklund has occupied. The transition in this office will involve identifying successor leadership within the company's San Francisco operations or recruiting qualified candidates to assume these accounting oversight responsibilities.